Trials
Search / Trial NCT06227273

Hydrogen Water Dosing Study for ME/CFS

Launched by STONY BROOK UNIVERSITY · Jan 17, 2024

Trial Information

Current as of March 08, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at the effects of hydrogen water on people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a condition that causes extreme fatigue and other symptoms. The study will last for 16 weeks and will involve two groups of participants. One group will drink a low amount of hydrogen water (about 2-3 glasses per day) for the entire study, while the other group will start with a low dose for the first 8 weeks and then increase to a higher dose (up to 5 glasses a day) for the last 8 weeks. The goal is to see if the higher dose is more effective at improving symptoms like fatigue and stress.

To participate, individuals need to be between 18 and 65 years old and meet certain health criteria for ME/CFS. They should be able to use a computer and have access to the internet for assessments. However, those with certain health conditions, psychiatric disorders, or a high body mass index (BMI over 35) will not be eligible. Participants can expect to complete online surveys about their fatigue and physical function during the study, and their saliva will be tested to look for a specific marker related to stress. This trial is currently recruiting, and it aims to provide valuable insights into a potential new treatment for ME/CFS.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Patients aged 18-65 of both sexes; considered physically capable and willing to perform the study tasks.
  • Meeting validated phone-screen eligibility for ME/CFS criteria.
  • Patient has internet and computer.
  • Exclusion Criteria:
  • Cases of fatigue clearly attributable to self-report medical conditions such as untreated hypothyroidism, unstable diabetes mellitus, organ failure, chronic infections, and chronic inflammatory diseases, or AIDS.
  • __ Exclusionary psychiatric disorders include any psychosis, or alcohol/ substance abuse within two years prior to illness onset and any time afterward, and current or past depression with melancholic or psychotic features within 5 years prior to onset of ME/CFS or anytime afterward
  • Pregnancy is an exclusion.
  • Patients with BMI\>35.
  • Patients at significant risk of suicide or in need of urgent psychiatric treatment. As much as possible, appropriate medical and psychiatric referrals to facilities local to subjects will be provided.

About Stony Brook University

Stony Brook University, a prominent research institution located in New York, is dedicated to advancing medical science through innovative clinical trials and research initiatives. As a sponsor, Stony Brook University leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient care and health outcomes. With a commitment to ethical standards and collaborative partnerships, the university fosters an environment conducive to groundbreaking discoveries and the translation of research findings into clinical practice.

Locations

Stony Brook, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0